Literature DB >> 7746979

A random-effects regression model for meta-analysis.

C S Berkey1, D C Hoaglin, F Mosteller, G A Colditz.   

Abstract

Many meta-analyses use a random-effects model to account for heterogeneity among study results, beyond the variation associated with fixed effects. A random-effects regression approach for the synthesis of 2 x 2 tables allows the inclusion of covariates that may explain heterogeneity. A simulation study found that the random-effects regression method performs well in the context of a meta-analysis of the efficacy of a vaccine for the prevention of tuberculosis, where certain factors are thought to modify vaccine efficacy. A smoothed estimator of the within-study variances produced less bias in the estimated regression coefficients. The method provided very good power for detecting a non-zero intercept term (representing overall treatment efficacy) but low power for detecting a weak covariate in a meta-analysis of 10 studies. We illustrate the model by exploring the relationship between vaccine efficacy and one factor thought to modify efficacy. The model also applies to the meta-analysis of continuous outcomes when covariates are present.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746979     DOI: 10.1002/sim.4780140406

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  207 in total

1.  Maternal smoking and the risk of early weaning: a meta-analysis.

Authors:  B L Horta; M S Kramer; R W Platt
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

2.  Diabetes and risk of esophageal and gastric adenocarcinomas.

Authors:  Xuejuan Jiang; Leslie Bernstein; Chiu-Chen Tseng; Anna H Wu
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

3.  Investigating the dose-response relation between air pollution and total mortality in the APHEA-2 multicity project.

Authors:  E Samoli; G Touloumi; A Zanobetti; A Le Tertre; Chr Schindler; R Atkinson; J Vonk; G Rossi; M Saez; D Rabczenko; J Schwartz; K Katsouyanni
Journal:  Occup Environ Med       Date:  2003-12       Impact factor: 4.402

4.  Short-term effects of particulate air pollution on cardiovascular diseases in eight European cities.

Authors:  A Le Tertre; S Medina; E Samoli; B Forsberg; P Michelozzi; A Boumghar; J M Vonk; A Bellini; R Atkinson; J G Ayres; J Sunyer; J Schwartz; K Katsouyanni
Journal:  J Epidemiol Community Health       Date:  2002-10       Impact factor: 3.710

Review 5.  Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials.

Authors:  John T Chang; Sally C Morton; Laurence Z Rubenstein; Walter A Mojica; Margaret Maglione; Marika J Suttorp; Elizabeth A Roth; Paul G Shekelle
Journal:  BMJ       Date:  2004-03-20

6.  Expanding the scope of risk assessment: methods of studying differential vulnerability and susceptibility.

Authors:  Joel Schwartz; David Bellinger; Thomas Glass
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

Review 7.  Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period.

Authors:  Marina Bianchi; Antonio Clavenna; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2010-06-09       Impact factor: 2.953

8.  The regional profile of antibiotic prescriptions in Italian outpatient children.

Authors:  Daniele Piovani; Antonio Clavenna; Massimo Cartabia; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2012-01-21       Impact factor: 2.953

Review 9.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

10.  Susceptibility to mortality in weather extremes: effect modification by personal and small-area characteristics.

Authors:  Antonella Zanobetti; Marie S O'Neill; Carina J Gronlund; Joel D Schwartz
Journal:  Epidemiology       Date:  2013-11       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.